In order to clarify the role of ATM rs1801516 as genetic determinant for late side effects of radiotherapy for breast cancer, in the present study we firstly examined its association with radiation-induced fibrosis or telangiectasia in a cohort of breast cancer patients who received radiotherapy after breast conserving surgery. Here, ATM is linked to breast cancer.